Gene · 9436
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation? | Eur Respir Rev | 2023 | 37437915 | PubTator, text mining | PubMed |
| Effects of sevoflurane on metalloproteinase and natural killer group 2, member D (NKG2D) ligand expression and natural killer cell-mediated cytotoxicity in breast cancer: an in vitro study. | Korean J Anesthesiol | 2023 | 37435613 | PubTator, text mining | PubMed |
| Complex interactions of cellular players in chronic Graft-versus-Host Disease. | Front Immunol | 2023 | 37435079 | PubTator, text mining | PubMed |
| AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation. | Front Immunol | 2023 | 37435061 | PubTator, text mining | PubMed |
| γδ T cells in immunotherapies for B-cell malignancies. | Front Immunol | 2023 | 37426670 | PubTator, text mining | PubMed |
| Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells. | iScience | 2023 | 37426355 | PubTator, text mining | PubMed |
| Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity. | Front Cell Infect Microbiol | 2023 | 37424786 | PubTator, text mining | PubMed |
| Novel microRNAs modulating ecto-5'-nucleotidase expression. | Front Immunol | 2023 | 37409119 | PubTator, text mining | PubMed |
| Identification of natural killer cell-related characteristics to predict the clinical prognosis and immune microenvironment of patients with low-grade glioma. | Aging (Albany NY) | 2023 | 37405952 | PubTator, text mining | PubMed |
| [Construction of NKG2D CAR-NK92 cells and its killing effect on multiple myeloma cells]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2023 | 37403715 | PubTator, text mining | PubMed |
| Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies. | Genes Dis | 2023 | 37396514 | PubTator, text mining | PubMed |
| Intragraft immune cells: accomplices or antagonists of recipient-derived macrophages in allograft fibrosis? | Cell Mol Life Sci | 2023 | 37395809 | PubTator, text mining | PubMed |
| Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective. | Exp Mol Med | 2023 | 37394580 | PubTator, text mining | PubMed |
| Cycloartenyl ferulate improves natural killer (NK) cell immunity against cancer by binding to IFNγ receptor 1. | J Biol Chem | 2023 | 37392850 | PubTator, text mining | PubMed |
| Murine models to study human NK cells in human solid tumors. | Front Immunol | 2023 | 37388731 | PubTator, text mining | PubMed |
| Attenuation of immune activation in patients with multiple sclerosis on a wheat-reduced diet: a pilot crossover trial. | Ther Adv Neurol Disord | 2023 | 37384112 | PubTator, text mining | PubMed |
| Transcriptional and chromatin profiling of human blood innate lymphoid cell subsets sheds light on HIV-1 pathogenesis. | EMBO J | 2023 | 37382276 | PubTator, text mining | PubMed |
| Research Progress of Dendritic Cell Surface Receptors and Targeting. | Biomedicines | 2023 | 37371768 | PubTator, text mining | PubMed |
| Recent Advances in CAR-Based Solid Tumor Immunotherapy. | Cells | 2023 | 37371075 | PubTator, text mining | PubMed |
| Enhancement of the Anticancer Ability of Natural Killer Cells through Allogeneic Mitochondrial Transfer. | Cancers (Basel) | 2023 | 37370835 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9436/papers?page=14